Can immunotherapy boost chemo for breast cancer? small study investigates
Knowledge-focused
Completed
This pilot study tested a combination of chemotherapy (Nab-Paclitaxel) and immunotherapy (Pembrolizumab) in 32 women with hormone receptor-positive, HER2-negative breast cancer before surgery. The main goal was to see how the treatment changed a biomarker called PD-L1 in tumor sa…
Phase: PHASE1 • Sponsor: Adrienne G. Waks • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC